"The sound of democracy - the sound of freedom" - Jazz-Rezeption in Deutschland (1945 - 1963)

Im Mittelpunkt der Studie "The Sound of Democracy - the Sound of Freedom". Jazzrezeption in Deutschland (1945 - 1963) steht ein Korpus von 16 Oral-History-Interviews mit Zeitzeugen der deutschen Jazzszene. Interviewt wurden Musiker ebenso wie bildende Künstler, Journalisten, Clubbesitzer und Jazzfans, die die Jazzszene in den 1950ern bildeten. Die Interviews werden in einen Kontext zeitgenössischer Quellen gestellt: Zeitschriftenartikel (hauptsächlich aus dem "Jazz Podium" ebenso wie Radiomanuskripte des Bayerischen Rundfunks.rnDie Ausgangsüberlegung ist die Frage, was der Jazz für sein Publikum bedeutete, mit anderen Worten, warum wählte eine studentische, sich selbst als elitär wahrnehmende Schicht aus dem großen Fundus an kulturellen Ausdrucksformen, die nach dem Zweiten Weltkrieg aus den USA nach Deutschland strömten, ausgerechnet den Jazz als persönliche Ausdrucksform? Worin bestand seine symbolische Strahlkraft für diese jungen Menschen?rnIn Zusammenhang mit dieser Frage steht die Überlegung: In welchem Maße wurde Jazz als dezidiert amerikanische Ausdrucksform wahrgenommen und welche Amerikabilder wurden durch den Jazz transportiert? Wurde Jazz bewusst als Werkzeug der Besatzer zur demokratischen Umerziehung des deutschen Volkes eingesetzt und wenn ja, in welcher Form, beziehungsweise in welchem Maß? Wie stark war die Symbolleistung und metaphorische Bedeutung des Jazz für das deutsche Publikum und in welchem Zusammenhang steht die Symbolleistung des Jazz mit der Symbolleistung der USA als Besetzungs- bzw. Befreiungsmacht? rn

Flagellin:allergen fusion proteins as novel vaccines for the treatment of severe type I allergies

Over the last decades the prevalence of food allergies has continually increased on a world wide scale. While there are effective treatments available for bee and wasp venom allergic patients, there is currently no established therapy for the treatment of severe food allergies. Aim of the project was to genetically fuse different food allergens with the immune modulating Toll-like receptor 5 (TLR5)-ligand flagellin and to test these constructs for their immune modulatory capacities both in vitro and in vivo. Chicken ovalbumin (Ova) as model antigen, Pru p 3, and Ara h 2 the respective major allergens from peach and peanut were used as allergens. The potential vaccine candidates were characterized by protein biochemical methods (purity, folding, endotoxin contaminations). Moreover, their immune modulating effects on cell culture lines (TLR5-receptor activation) and primary mouse immune cells (myeloid and plasmacytoid dendritic cells) were investigated. Additionally, the prophylactic and therapeutic use of the flagellin Ova fusion protein (rflaA:Ova) were investigated in a mouse model of intestinal allergy. In myeloid dendritic cells (mDC) stimulation with the fusion proteins led to a strong cell activation and cytokine secretion. Here, the fusion proteins proved to be a much stronger stimulus than the equimolar amount of both proteins provided alone or as a mixture. Noteworthy, stimulation with rflaA:Ova induced the secretion of the anti-inflammatory cytokine IL-10 from mDC. In co-culture experiments this IL-10 secretion suppressed the Ova-induced secretion of Th1 and Th2 cytokines from Ova-specific CD4 T cells. Using MyD88-deficient mDC this repression of cytokine secretion was shown to be TLR-dependent. Finally, the potency of the rflaA:Ova construct was investigated in a mouse model of Ova-induced intestinal allergy. In a prophylactic vaccination approach rflaA:Ova was shown to prevent the establishment of the intestinal allergy and all associated symptoms (weight loss, temperature drop, soft faeces). This fusion protein-mediated protection was accompanied by a reduced T cell activation, and reduced Th2 cytokines in intestinal homogenates. These effects were paralleled by a strong induction of Ova-specific IgG2a antibodies in rflaA:Ova-vaccinated sera, while Ova-specific IgE antibody production was significantly reduced. Therapeutic vaccination with rflaA:Ova reduced allergic symptoms and T cell activation but did not influence weight loss and antibody production. In all in vivo experiments vaccination with both proteins either provided alone or as a mixture did not have comparable effects. Future experiments aim at elucidating the mechanism and further optimization of the therapeutic vaccination approach. The results presented in this thesis demonstrate, that fusion proteins containing flagellin have strong immune modulatory capacities both in vitro and in vivo. Therefore, such constructs are promising vaccine candidates for the therapy of type I allergies.